11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas

Nuclear Medicine and Biology

Volumn 39, Issue 3, 2012, Pages 437-442

  Li, Fang Ming ^a   Nie, Qing ^a   Wang, Rui Min ^c   Chang, Susan M ^b   Zhao, Wen Rui ^a   Zhu, Qi ^a   Liang, Ying Kui ^a   Yang, Ping ^a   Zhang, Jun ^a   Jia, Hai Wei ^a   Fang, Heng Hu ^a  

^a NAVY GENERAL HOSPITAL   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Nuclear Medicine   (China)

Author keywords

Brain glioma; MRI; PET imaging; Radioactive carbon labeled choline; Radiotherapy regimen; Radiotherapy target volume

Indexed keywords

CHOLINE C 11; CARBON; CHOLINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN METABOLISM; BRAIN SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; SCHOOL CHILD; TARGET ORGAN; TREATMENT PLANNING; TUMOR VOLUME; BRAIN TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CHILD; CHOLINE; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 84858151072     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.10.003     Document Type: Article

References (18)

1. Grosu A.L., Weber W.A. PET for radiation treatment planning of brain tumors. Radiother Oncol 2010, 96:325-327.
2. Pirotte B.J., Levivier M., Goldman S., et al. PET-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery 2009, 64:471-481.
3. Wyss M., Hofer S., Brurhlmeier M., et al. Early metabolic responses in temozolomide treated low-grade glioma patients. J Neurooncol 2009, 95:87-93.
4. Bussink J., van herpen C.M.L., Kaanders J.H.A.M., Oyen W.J.G. PET-CT for response assessment and treatment adaptation in head and neck cancer. Lancet Oncol 2010, 11:661-669.
5. Ohtani T., Kurihara H., Ishiuchi S., et al. Brain tumor imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001, 28:1664-1670.
6. 11C-choline as contrast agents in PET imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 2003, 99:474-479.
7. 11C-choline PET. Am J Neuroradiol 2008, 29:1176-1182.
8. Zhang C., Yang S.Y., Zhu T., et al. Improved resection for gliomas using positron emission tomography/computerized tomography neuro-navigation. Chin J Neurosurg 2007, 23:83-86.
9. 18F]Fluoroethyl)-l-tyrosine PET combined with MRI improve the diagnostic assessment of cerebral gliomas. Brain 2005, 128:678-687.
10. 11C-methionine PET: local comparison with stereotactic histopathology. J Clin Cancer Res 2004, 10:7163-7170.
11. 11C]MET in 45 PET-guided stereotactic brain biopsies. J Neurosurg 2004, 101:476-483.
12. 11C-MET PET- guided stereotactic brain biopsy in gliomas. J Nucl Med 2004, 45:1293-1298.
13. Levivier M., Massager N., Wikler D., et al. Use of stereotactic PET images in dosimetry planning of radio-surgery for brain tumors: clinical experience and proposed classification. J Nucl Med 2004, 45:1146-1154.
14. Nestle U., Weber W., Hentschel M., et al. Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol 2009, 54:R1-R25.
15. Miwa K., Matsuo M., Shinoda J., et al. Hypo-fractionated high-dose irradiation planned by methionine PET for the treatment of glioblastoma multiform. Int J Radiat Oncol Biol Phys 2010, 78:S260-S261. (supplement).
16. 11C-MET PET with MRI for target volume delineation in post-operative radiotherapy for brain high grade gliomas. Chin J Radiat Oncol 2010, 19:415-419.
17. Miwa K., Shinoda J., Yano H., et al. Discrepancy between lesion distribution on MET-PET and MRI image in patients with glioblastoma multiform: insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 2004, 75:1457-1462.
18. Grosu A.L., Weber W.A., Franz M., et al. Reirradiation of recurrent high-grade gliomas using amino acid PET/CT/MRI image fusion to determine gross tumor volume for stereotactic fractional radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:511-519.